Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results

HAMILTON, BERMUDA, Sept. 12, 2023 --  Company hosts 1H 2023 Financial Results and Business Update call today at 8 a.m. ET First research collaboration with biopharmaceutical company initiated...

Related Keywords

United States ,Australia ,Norway ,Denver ,Colorado ,Switzerland ,Finland ,Bermuda ,London ,City Of ,United Kingdom ,Sweden ,Denmark ,Boston ,Massachusetts ,Thomas Meyer ,Covadonga Pa ,Maria Grunwald ,Delivery Technology ,Nasdaq ,Securities Exchange Commission ,Securities Exchange ,Osteoarthritis Research Society International World Congress ,Altamira Therapeutics Ltd ,King College London ,Washington University School Of Medicine St ,Business Update ,Altamira Therapeutics ,Heqet Therapeutics ,Washington University School ,Senior Business ,Total Nasal Symptom Score ,Pharma Nordic ,Financial Guidance ,Conference Call ,Altamira Therapeutics First Half ,Access Code ,Consolidated Interim Statement ,Six Months Ended June ,Financial Position ,Securities Act ,Securities Exchange Act ,Annual Report ,Markets ,